Ars Pharmaceuticals CEO sells over $900k in company stock By Investing.com
[ad_1] © Reuters. In a recent transaction, Richard E. Lowenthal, President and CEO of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), has sold a significant amount of company...